GSK ' s RSV Vaccine First to Get EU Regulator ' s Nod GSK ' s RSV Vaccine First to Get EU Regulator ' s Nod

The European Medicines Agency (EMA) on Wednesday recommended authorization of GSK ' s Arexvy vaccine for respiratory syncytial virus in adults aged 60 and older.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Infectious Diseases News Source Type: news